Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorCihan, Pınar
dc.date.accessioned2022-05-11T14:03:00Z
dc.date.available2022-05-11T14:03:00Z
dc.date.issued2021
dc.identifier.issn1568-4946
dc.identifier.urihttps://doi.org/10.1016/j.asoc.2021.107708
dc.identifier.urihttps://hdl.handle.net/20.500.11776/4571
dc.description.abstractCoronavirus disease 2019 (COVID-2019) has spread rapidly all over the world and it is known that the most effective way to eliminate the disease is vaccination. Although the traditional vaccine development process is quite long, more than ten COVID-19 vaccines have been approved for use in about a year. The COVID-19 vaccines that have been administered are highly effective enough, but achieving herd immunity is required to end the pandemic. The motivation of this study is to contribute to review the countries’ vaccine policies and adjusting the manufacturing plans of the vaccine companies. In this study, the total number of people fully vaccinated against COVID-19 was forecasted in the US, Asia, Europe, Africa, South America, and the World with the Autoregressive Integrated Moving Average (ARIMA) model, which is a new approach in vaccination studies. Additionally, for herd immunity, the percentage of fully vaccinated people in these regions at the beginning of 2021 summer was determined. ARIMA results show that in the US, Asia, Europe, Africa, South America, and the World will reach 139 million, 109 million, 127 million, 8 million, 38 million, and 441 million people will be fully vaccinated on 1 June 2021, respectively. According to these results, 41.8% of the US, 2.3% of Asia, 17% of Europe, 0.6% of Africa, 8.8% of South America, and 5.6% of the World population will be fully vaccinated people against the COVID-19. Results show that countries are far from the herd immunity threshold level desired to reach for safely slow or stop the COVID-19 epidemic. © 2021en_US
dc.description.sponsorshipNo funding to declare.en_US
dc.language.isoengen_US
dc.publisherElsevier Ltden_US
dc.identifier.doi10.1016/j.asoc.2021.107708
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectARIMAen_US
dc.subjectCOVID-19en_US
dc.subjectForecastingen_US
dc.subjectHerd immunityen_US
dc.subjectSARS-CoV-2en_US
dc.subjectVaccineen_US
dc.subjectAutoregressive moving average modelen_US
dc.subjectAutoregressive integrated moving average modelsen_US
dc.subjectHerd immunitiesen_US
dc.subjectManufacturing plansen_US
dc.subjectNew approachesen_US
dc.subjectNumber of peoplesen_US
dc.subjectThreshold levelsen_US
dc.subjectVaccine developmenten_US
dc.subjectWorld populationen_US
dc.subjectVaccinesen_US
dc.titleForecasting fully vaccinated people against COVID-19 and examining future vaccination rate for herd immunity in the US, Asia, Europe, Africa, South America, and the Worlden_US
dc.typearticleen_US
dc.relation.ispartofApplied Soft Computingen_US
dc.departmentFakülteler, Çorlu Mühendislik Fakültesi, Bilgisayar Mühendisliği Bölümüen_US
dc.identifier.volume111en_US
dc.institutionauthorCihan, Pınar
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid56539994200
dc.identifier.wosWOS:000724665600019en_US
dc.identifier.scopus2-s2.0-85110439312en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster